Incyte
INCY
#1152
Rank
โ‚น1.924 T
Marketcap
โ‚น9,631
Share price
-1.70%
Change (1 day)
60.69%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2026 (TTM): โ‚น157.80 Billion

According to Incyte's latest financial reports the company's current earnings are โ‚น5.36 Billion. In 2025 the company made an earning of โ‚น159.28 Billion, an increase over its 2024 earnings that were of โ‚น30.30 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น157.80 B-0.93%
2025 โ‚น159.28 B425.68%
2024 โ‚น30.30 B-62.04%
2023 โ‚น79.83 B57.66%
2022 โ‚น50.63 B-7.24%
2021 โ‚น54.59 B-345.65%
2020 -โ‚น22.23 Billion-147.7%
2019 โ‚น46.58 B322.02%
2018 โ‚น11.03 B-136.94%
2017 -โ‚น29.89 Billion-390.76%
2016 โ‚น10.27 B1322%
2015 โ‚น0.72 B-115.56%
2014 -โ‚น4.65 Billion-41.4%
2013 -โ‚น7.93 Billion87.67%
2012 -โ‚น4.23 Billion-74.9%
2011 -โ‚น16.83 Billion843.59%
2010 -โ‚น1.79 Billion-88.68%
2009 -โ‚น15.76 Billion1.37%
2008 -โ‚น15.55 Billion86.16%
2007 -โ‚น8.35 Billion17.64%
2006 -โ‚น7.1 Billion-28.62%
2005 -โ‚น9.95 Billion-36.1%
2004 -โ‚น15.57 Billion-2.03%
2003 -โ‚น15.89 Billion22.26%
2002 -โ‚น13 Billion-27.39%
2001 -โ‚น17.9 Billion198.72%
2000 -โ‚น5.99 Billion132.2%
1999 -โ‚น2.58 Billion-556.86%
1998 โ‚น0.56 B-37.23%
1997 โ‚น0.89 B-259.32%
1996 -โ‚น0.57 Billion-45.87%
1995 -โ‚น1.05 Billion-9.17%
1994 -โ‚น1.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.510 T 789.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น1.013 T 497.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.978 T 1,654.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น869.60 B 412.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น15.66 B-90.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น4.87 Billion-102.87%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น6.63 Billion-103.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น2.78 Billion-101.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น5.55 Billion-103.27%๐Ÿ‡บ๐Ÿ‡ธ USA